Search
New hope for the 20 percent of kids who don't respond to standard cancer treatment
- OPACC
- Oct 27, 2015
- 1 min read
A new drug combination being trialled in a groundbreaking CHU Sainte-Justine/University of Montreal study is giving hope for survival, healing and improved quality of life to the 20% of children who do not respond to standard cancer treatments.
Recent Posts
See AllDuring cancer treatment, children can face hurdles to maintaining healthy eating. Chemotherapy has many side effects, including loss of...
Quality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
Comentários